DPP4 and neoplasm: In conclusion, our findings suggest that the specimen CD26 expression level is an independent prognostic marker which predicts survival significantly before development of metastasis, and it can provide additional prognostic information and allow selection of CRC patients at high risk of tumour recurrence or development metastasis for adjuvant or neoadjuvant therapy.